Amarin | AMRN - Kapitalisasi Pasar





Kapitalisasi Pasar Perubahan Tanggal
AbbVie USD 403.83B 5.2B 2025-12
Alnylam Pharmaceuticals USD 52.54B 7.24B 2025-12
Amarin USD 308M 18M 2026-03
AstraZeneca USD 220.14B 68B 2026-03
BioCryst Pharmaceuticals USD 1.7B 40M 2026-03
DBV Technologies USD 774M 500M 2026-03
Esperion Therapeutics USD 475M 410M 2026-03
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
Neurocrine Biosciences USD 14.14B 218M 2025-12
Novartis USD 240.48B 51.73B 2026-03